Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
Nae-Yun Heo
Clin Mol Hepatol. 2017;23(2):125-127.   Published online 2017 Jun 23     DOI: https://doi.org/10.3350/cmh.2017.0106
Citations to this article as recorded by Crossref logo
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
Edward J. Gane, Won Kim, Tien Huey Lim, Pisit Tangkijvanich, Jung-Hwan Yoon, William Sievert, Wattana Sukeepaisarnjaroen, Alexander J. Thompson, Vedran Pavlovic, Bernadette Surujbally, Cynthia Wat, Bob D. Brown, Hardean E. Achneck, Man-Fung Yuen
Journal of Hepatology.2023; 79(5): 1139.     CrossRef
Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B
Edward Gane, Man‐Fung Yuen, Dong Joon Kim, Henry Lik‐Yuen Chan, Bernadette Surujbally, Vedran Pavlovic, Sudip Das, Miriam Triyatni, Remi Kazma, Joseph F. Grippo, Simon Buatois, Annabelle Lemenuel‐Diot, Ben‐Fillippo Krippendorff, Henrik Mueller, Yuchen Zha
Hepatology.2021; 74(4): 1795.     CrossRef
Tenofovir disoproxil fumarate-induced severe liver injury in a patient with chronic hepatitis B virus infection
Min Kyu Kang, Jung Gil Park
Digestive and Liver Disease.2018; 50(6): 628.     CrossRef